Advertisements


Roche Holding"s (RHHBY) Virtual Late Stage Pipeline Event 2018 - Slideshow

Roche Holding"s (RHHBY) Virtual Late Stage Pipeline Event 2018 - Slideshow.....»»

Category: topSource: seekingalphaSep 14th, 2018

Roche Holding Ltd (RHHBY) Management on Virtual Pipeline Event 2018 World Conference on Lung Cancer Conference Call (Transcript)

Roche Holding Ltd (RHHBY) Management on Virtual Pipeline Event 2018 World Conference on Lung Cancer Conference Call (Transcript).....»»

Category: topSource: seekingalphaSep 26th, 2018

Roche gets go-ahead from FDA for COVID-19 clinical trial

Shares of Roche Holding AG are down 3% in trading on Monday after the drugmaker said it had received regulatory approval to begin a late-stage clinical trial examining the safety and effectiven.....»»

Category: topSource: marketwatchMar 23rd, 2020

Roche Holding (RHHBY) Presents At 2019 ASH Annual Meeting - Slideshow

Roche Holding (RHHBY) Presents At 2019 ASH Annual Meeting - Slideshow.....»»

Category: topSource: seekingalphaDec 10th, 2019

Roche Holding AG (RHHBY) Investor Presentation - Slideshow

Roche Holding AG (RHHBY) Investor Presentation - Slideshow.....»»

Category: topSource: seekingalphaNov 14th, 2019

Roche Holding Ltd ADR (RHHBY) Presents At 2019 ASCO Annual Meeting - Slideshow

Roche Holding Ltd ADR (RHHBY) Presents At 2019 ASCO Annual Meeting - Slideshow.....»»

Category: topSource: seekingalphaJun 6th, 2019

Roche Holding"s (RHHBY) CEO Severin Schwan on Q1 2018 Results - Earnings Call Transcript

Roche Holding"s (RHHBY) CEO Severin Schwan on Q1 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaApr 27th, 2018

Roche Holding ADR (RHHBY) Presents At Deutsche Bank Securities Inc. DbAccess Berlin Conference - Slideshow

Roche Holding ADR (RHHBY) Presents At Deutsche Bank Securities Inc. DbAccess Berlin Conference - Slideshow.....»»

Category: topSource: seekingalphaJun 6th, 2018

Roche"s Tecentriq Met Primary Goal in First-Line NSCLC Study

Roche's (RHHBY) late-stage lung cancer study on immuno-oncology drug, Tecentriq, meets its co-primary endpoint of progression-free survival (PFS). Roche H.....»»

Category: dealsSource: nytJul 19th, 2018

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q2 2018 Results - Earnings Call Transcript

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q2 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaJul 26th, 2018

Roche Announces Positive Data on Breast Cancer Drug Kadcyla

Roche's (RHHBY) breast cancer drug Kadcyla, in a late-stage study in patients suffering from HER2-positive eBCmet, met its goal. Roche RHHBY announced encouraging results from a phase III st.....»»

Category: smallbizSource: nytOct 16th, 2018

Roche Holding Ltd (RHHBY) CEO Severin Schwan on Q3 2018 Results - Earnings Call Transcript

Roche Holding Ltd (RHHBY) CEO Severin Schwan on Q3 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaOct 18th, 2018

Roche Holding Ltd (RHHBY) Management Presents at 2018 American Society of Hematology"s 60th Annual Meeting Conference (Transcript)

Roche Holding Ltd (RHHBY) Management Presents at 2018 American Society of Hematology"s 60th Annual Meeting Conference (Transcript).....»»

Category: topSource: seekingalphaDec 5th, 2018

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q4 2018 Results - Earnings Call Transcript

Roche Holding Ltd ADR (RHHBY) CEO Severin Schwan on Q4 2018 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaFeb 1st, 2019

3 Cancer Diagnostic Stocks To Watch Following Roche"s GenMark Buy

Roche Holding AG (OTC: RHHBY) acquired GenMark Diagnostics, Inc (NASDAQ: GNMK) in a read more.....»»

Category: blogSource: benzingaMar 16th, 2021

Roche Boosts Diagnostics Portfolio With $1.8B Bet On COVID-19 Test Manufacturer GenMark

Swiss drug giant Roche Holding AG (OTC: RHHBY) announced a big-ticket acquisition that would boost its presence in the diagnostics market, setting the tempo for a merger Monday. read more.....»»

Category: blogSource: benzingaMar 15th, 2021

Biohaven Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent Business Developments

NEW HAVEN, Conn., May 7, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN, the "Company"), a commercial-stage biopharmaceutical company with a portfolio of innovative, late-stage product ca.....»»

Category: earningsSource: benzingaMay 7th, 2020

Roche Receives FDA Emergency Approval To Ship 400,000 Coronavirus Test Kits Across US

Roche Holding AG (OTC: RHHBY) is shipping COVID-19 test kits approved under emergency use authorization (EUA) by the FDA. read more.....»»

Category: blogSource: benzingaMar 17th, 2020

Roche Holding News: RHHBY Stock Jumps 8% on Faster Coronavirus Test

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Roche Holding (RHHBY) news for Fr.....»»

Category: topSource: investorplaceMar 14th, 2020

Roche"s Faster Coronavirus Test Receives FDA Emergency Use Authorization

Roche Holding AG (OTC: RHHBY) announced Friday that the FDA has issued an emergency use authorization for its cobas SARS-CoV-2 test, which aims to speed up the ability to test patients for the coronavirus.  read more.....»»

Category: blogSource: benzingaMar 13th, 2020

Aldeyra to prioritize late-stage ocular disease pipeline

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 12th, 2020